TB-500 × Kimera Chems - Lab Test, December 2025
Trust Pointe Analytics publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
Test results
About this test
This independent HPLC lab test confirms the TB-500 component in the BPC-157/TB-500 combination (5mg/5mg) from Kimera Chems at 99.678% blend purity. The analysis was conducted by Trust Pointe Analytics on December 18, 2025.
TB-500 is a synthetic peptide derivative of thymosin beta-4, researched for its role in wound healing, tissue repair, and potential regenerative applications. The blend purity level of 99.678% indicates minimal contamination in the combined product formulation.
The report tested 1 vial with TB-500 content: 5.499mg (tested assay).
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.